Newsfeeds - Spark Newswire

3 minute read

Lexaria Bioscience Announces Initial Results From Human Clinical Study Of DehydraTECHTM; Study Evidences Up To 23% Decrease In Blood Pressure With DehydraTECH-CBD Relative to Placebo

Today, 9:33 PM

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is extremely pleased to issue initial results from human clinical study

LEXX

2 minute read

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targets Burgeoning Hypertension, Antiviral Therapeutics Markets With Drug Delivery Technology

By InvestorBrandNetwork

Today, 9:33 PM

Lexaria has progressed significantly in evidencing that its patented DehydraTECH(TM) drug delivery technology can sufficiently improve the usable fraction of known antiviral drugs that reach the bloodstream. According to a Newsfile Corp. article, this technology can be applied to rendering treatments for HIV/AIDS and other infectious diseases more effective

LEXX

7 minute read

Penny Stocks

Lexaria’s DehydraTECH-CBD Lowers Blood Pressure

By The Newswire

Today, 9:33 PM

Human Clinical Study HYPER-H21-1 evidences a rapid and sustained drop in blood pressure with DehydraTECH-CBD and excellent tolerability…

LEXX

1 minute read

Lexaria Bioscience Shares Halted On Circuit Breaker To Upside; Traders Circulate Business Insider Report Mentioning Co As ‘Top Short Squeeze’ Name

By Benzinga Newsdesk

Today, 9:33 PM

https://www.businessinsider.com/stocks-to-buy-5-likely-short-squeeze-candidates-july-25-2021-7

LEXX

5 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:33 PM

Gainers

ABSI

1 minute read

EXCLUSIVE: Lexaaria Biosciences CEO Chris Bunka Tells Benzinga that Use of DehydraTECH-enabled Colchcine Results in Increased Drug Delivery and Concentration Into the Bloodstream by 167% and 91% Respectively in Mitigating the Cytokine Storm Associated…

By Charles Gross

Today, 9:33 PM

Lexaria issued a press release earlier today regarding possible benefits of DehydraTECH-enabled Colchcine for treating SARS-CoV-2/COVID-19 and mRNA vaccine side effects

LEXX

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 9:33 PM

Gainers

ARDS

2 minute read

Mid-Afternoon Market Update: Dow Jumps 250 Points; Sleep Number Shares Slide After Q2 Results

By Lisa Levin

Today, 9:33 PM

Toward the end of trading Wednesday, the Dow traded up 0.73% to 34,765.42 while the NASDAQ rose 0.66% to 14,594.38. The S&P also rose, gaining 0.69% to 4,352.90.

BTU

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 9:33 PM

CEMI

2 minute read

Mid-Day Market Update: Crude Oil Up 4%; Chembio Diagnostics Shares Spike Higher

By Lisa Levin

Today, 9:33 PM

Midway through trading Wednesday, the Dow traded up 0.79% to 34,785.02 while the NASDAQ rose 0.59% to 14,584.15. The S&P also rose, gaining 0.70% to 4,353.50.

BTU